CHinese Acute Tissue-Based Imaging Selection for Lysis In Stroke -Tenecteplase

NCT04086147 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

86

Enrollment

OTHER

Sponsor class

Conditions

Stroke

Interventions

DRUG: Low dose tenecteplase
DRUG: High dose tenecteplase

Sponsor

Huashan Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]